China Universal Asset Management Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

China Universal Asset Management Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96.2K	Hold	608	–	–	0.01%	419
2026 Q1	$77.7K	Hold	608	–	–	0.01%	427
2025 Q4	$74.1K	Sell	608 -4,311	-88%	-$494K	0.01%	427
2025 Q3	$493K	Buy	4,919 +4,411	+868%	+$397K	0.04%	250
2025 Q2	$42.1K	Sell	508 -7,514	-94%	-$599K	﹤0.01%	426
2025 Q1	$651K	Hold	8,022	–	–	0.06%	219
2024 Q4	$722K	Sell	8,022 -15,101	-65%	-$1.46M	0.07%	205
2024 Q3	$2.28M	Sell	23,123 -7,833	-25%	-$770K	0.25%	85
2024 Q2	$2.87M	Sell	30,956 -3,924	-11%	-$352K	0.4%	56
2024 Q1	$3.31M	Buy	34,880 +25,976	+292%	+$2.41M	0.42%	51
2023 Q4	$795K	Hold	8,904	–	–	0.15%	125
2023 Q3	$650K	Hold	8,904	–	–	0.19%	98
2023 Q2	$741K	Buy	8,904 +8,750	+5,682%	+$732K	0.23%	95
2023 Q1	$11.7K	Sell	154 -16,783	-99%	-$1.39M	﹤0.01%	272
2022 Q4	$1.41M	Buy	16,937 +14,576	+617%	+$1.18M	0.57%	58
2022 Q3	$187K	Buy	+2,361	New	+$199K	0.08%	93

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

China Universal Asset Management Company's XBI Position: Q2 2026 in Review

China Universal Asset Management Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 608 shares worth $96.2K. The position accounts for 0.01% of the portfolio, ranked #419.

China Universal Asset Management Company first reported a position in XBI in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.31M in Q1 2024. 654 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

China Universal Asset Management Company held 608 shares of State Street SPDR S&P Biotech ETF worth $96.2K as of Q2 2026.
China Universal Asset Management Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #419 holding.
China Universal Asset Management Company first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 16 quarters since.
China Universal Asset Management Company's State Street SPDR S&P Biotech ETF position peaked at $3.31M in Q1 2024.
654 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.